Wang, YaboGonzalez, MichelCheng, CaiHaouala, AminaKrueger, ThorstenPeters, SolangeDecosterd, Laurent-Arthurvan den Bergh, HubertPerentes, Jean Y.Ris, Hans-BeatLetovanec, IgorDebefve, Elodie2012-05-032012-05-032012-05-03201210.1002/lsm.22013https://infoscience.epfl.ch/handle/20.500.14299/79957WOS:000302615500007Visudyne®-mediated photodynamic therapy (PDT) at low drug/light conditions has shown to selectively enhance the uptake of liposomal doxorubicin in subpleural localized sarcoma tumors grown on rodent lungs without causing morphological alterations of the lung. The present experiments explore the impact of low-dose PDT on liposomal doxorubicin (Liporubicin™) uptake to different tumor types grown on rodent lungs.adenocarcinomachemotherapylungphotodynamic therapymesotheliomasarcomaMalignant Pleural MesotheliomaRandomized Phase-IiiBreast-CancerM-TetrahydroxyphenylchlorinTherapyTrialModelVerteporfinCarcinomaPerfusionPhotodynamic induced uptake of liposomal doxorubicin to rat lung tumors parallels tumor vascular densitytext::journal::journal article::research article